How is iAluRil administered?

iAluRil is instilled directly into the bladder either by a catheter, or via the iAluadapter^® for catheter-free administration.

Via a catheter

Any residual urine is drained away and iAluRil is passed through the catheter into your bladder. The catheter is then removed, leaving the solution in your bladder.

Via the iAluadapter

You will need to pass urine immediately prior to treatment. The iAluadapter tip is inserted into the urethra and iAluRil is instilled into the bladder through this.

iAluadapter

The iAluadapter is a small tip that attaches to the end of the iAluRil syringe. It allows administration of iAluRil without the need for a catheter so enables treatment to more comfortably continue at home. It comes as standard in each iAluRil box.

The end part fits securely to the iAluRil pre-filled syringe.
The ribbed centrepiece provides a secure grip when fitting to the syringe.
The concave isolating collar is made from a flexible material that adapts to the urethral opening, facilitating instillation without leakage.
The radiused tip part is the only part of the device to penetrate into the urethral opening. It is shaped to maximise effectiveness and ease of use.

Where can iAluRil be administered?

iAluRil can either be administered by a Urology Nurse in a hospital/clinic, or self-administered by yourself at home. Usually your first instillations will be done within the Urology Department by a clinician, but they may then show you how to administer iAluRil yourself at home, if you wish.

Nurse administration in a hospital/clinic

Administration only takes a few minutes, but for the first treatment you might be asked to stay within the department for an hour or until you need to pass urine. You will be able to leave straight after administration for subsequent treatments.
A urine sample will be tested prior to each administration. If infection is suspected, your treatment may be postponed whilst you take a course of antibiotics.

Self-administration at home

iAluRil can be self-administered at home either using intermittent self-catheterisation (ISC) or using the iAluadapter.
NB. Self-administration should only be carried out following appropriate training; either by a nurse, or by watching our training videos below.

Self-administration support

Some patients might feel uneasy when they are about to get started with self-administration.
But don’t worry; most people get over that feeling as soon as they have tried it a few times.

We’ve put together some videos to take you through self-administration using the iAluadapter
or intermittent self-catheterisation (ISC) at home.

Self-administration for women

Self-administration for men

There is much more information available to support you with self-administration; either using the iAluadapter, or intermittent self-catheterisation (ISC) on the support page.

Step-by-step instructions
Patient information
Tip sheets
Information leaflets
Contact details for nurse support and patient charities

Find out more

How many treatments will I need?

iAluRil treatment begins with a course of instillations given once a week for the first month.

After that, treatment intervals vary depending on diagnosis:

Diagnosis	Number of instillations	Administration regime
Recurrent Urinary Tract Infection	9	Weekly for 4 weeks, then monthly for 5 months. You may receive a short course of prophylactic antibiotics to enable treatment to be given.
Bladder Pain Syndrome/ Interstitial Cystitis	6 initially	Weekly for 4 weeks, then at weeks 6 and 8. Further treatment will be agreed with your nurse or urologist.
Chemical induced Cystitis	8	Weekly for 8 weeks.
Radiation induced cystitis	7	Weekly for 4 weeks, then at weeks 6, 8 and 12.

You will be given a treatment schedule to follow at home.

Note: you may need 4-6 treatments before your symptoms improve, so don’t be discouraged if the treatment does not work immediately.
In some instances, your consultant may request a further course of iAluRil® treatment in the future.

iAluRil should only be used after careful consultation with a trained healthcare professional.
If you are unsure about your diagnosis, please speak to your Urologist, Urology Nurse or another Health Care Professional.

Always read the label.

Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in the product’s package leaflet.
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects, you can help provide more information on the safety of this medicine.

IAL1010244F2_DEC2023